Clearasil Stubborn Acne Control 5in1 Daily Pads

Description

Clearasil® Stubborn Acne Control 5in1 Daily Pads contain salicylic acid as the active ingredient, formulated to address five persistent acne issues: blocked pores, pimple size, excess oil, acne marks, and blackheads. Each pad measures 2.19 inches (5.56 cm) in diameter and is designed for daily use. The product is packaged with a total of 90 pads, providing a comprehensive solution for acne management.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product should be applied by wiping a pad over the face and neck, ensuring that the entire affected area is covered with a thin layer.

Initial dosing should consist of one application daily. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily. It is important to monitor for excessive drying of the skin, which may necessitate a reduction in application frequency. If bothersome dryness or peeling occurs, the application should be adjusted to once a day or every other day to mitigate these effects.

Contraindications

There are no specific contraindications listed for this product. However, healthcare professionals should advise patients to discontinue use and consult a physician if skin or eye irritation develops.

Contact with the eyes should be avoided; in the event of exposure, the eyes must be rinsed thoroughly with water. The risk of skin irritation and dryness may increase if used concurrently with other topical acne medications; therefore, it is recommended to use only one topical acne medication at a time if irritation occurs. Additionally, the product should be limited to application on the face and neck.

Warnings and Precautions

For external use only. This product is flammable until dry; therefore, it is imperative to keep it away from extreme heat or open flame to prevent fire hazards.

In the event of skin or eye irritation, the user should discontinue use immediately and consult a healthcare professional for further evaluation and guidance.

It is essential to keep this product out of reach of children. In the case of accidental ingestion, seek medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of several important safety considerations. The product is intended for external use only and is flammable until dry; therefore, it should be kept away from extreme heat or open flame.

During use, patients are advised to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water. Skin irritation and dryness may occur, particularly if the patient is using another topical acne medication concurrently. To minimize the risk of irritation, it is advised that only one topical acne medication be used at a time.

Patients should discontinue use and consult a healthcare professional if skin or eye irritation develops. Additionally, the product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or the Poison Control Center should be contacted without delay.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Clearasil Stubborn Acne Control 5in1 Daily Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

The product is intended for use on the face and neck only. Due to the potential for excessive drying of the skin, it is recommended to initiate treatment with one application daily. Dosage may be gradually increased to two or three times daily as needed or as directed by a healthcare professional.

If patients experience bothersome dryness or peeling, they should reduce the frequency of application to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of Clearasil Stubborn Acne Control 5in1 Daily Pads in geriatric patients. The prescribing information does not indicate any dosage adjustments, safety concerns, or special precautions that are applicable to elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in patients aged 65 and older, as individual patient factors may influence treatment decisions. Monitoring for any adverse effects or reactions is advisable, given the lack of targeted data for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the possibility of teratogenic effects. Pregnant patients are advised to consult a healthcare provider before using this product to discuss potential risks and alternative options.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants during lactation.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when treating patients with renal impairment, as specific recommendations are not provided in the current data.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management of overdosage should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Individuals are encouraged to report any adverse events to the designated phone number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to stop using the product and consult a doctor if they experience any skin or eye irritation. When using this product, it is essential to avoid contact with the eyes. In the event that the product comes into contact with the eyes, patients should rinse thoroughly with water.

Additionally, healthcare providers should caution patients that skin irritation and dryness are more likely to occur if they use another topical acne medication simultaneously. If irritation does occur, patients should be advised to use only one topical acne medication at a time. Finally, it is important to limit the use of this product to the face and neck only.

Storage and Handling

The product is supplied in a jar that must be kept tightly closed to maintain its integrity. It should be stored in a cool, dry place, ensuring that it does not freeze. It is important to note that the product should not be flushed down the toilet.

Additional Clinical Information

The product is administered topically, with patients instructed to apply a thin layer over the entire affected area of the face and neck one to three times daily. Clinicians should advise patients to avoid contact with the eyes; if contact occurs, the area should be rinsed thoroughly with water.

Patients are cautioned that using this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. It is recommended to limit application to the face and neck, and to discontinue use and consult a doctor if any skin or eye irritation develops. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if swallowed.

Drug Information (PDF)

This file contains official product information for Clearasil Stubborn Acne Control 5in1 Daily Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)